Amarin Corp Plcuk (AMRN) Total Debt Growth (3y) (2013 - 2020)
Amarin Corp Plcuk (AMRN) Total Debt Growth (3y) (2013 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 2.45% |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 5.09% |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 13.46% |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | -19.32% |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 51.71% |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | -0.51% |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -0.71% |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | -1.11% |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 0.14% |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -41.79% |
| Jun 30, 2020 | -23.04% |
| Mar 31, 2020 | -9.52% |
| Dec 31, 2019 | -0.42% |
| Sep 30, 2019 | 57.83% |
| Jun 30, 2019 | -24.03% |
| Mar 31, 2019 | -21.13% |
| Dec 31, 2018 | -18.64% |
| Sep 30, 2018 | -15.66% |
| Jun 30, 2018 | -14.53% |
| Mar 31, 2018 | -13.18% |
| Dec 31, 2017 | -12.11% |
| Sep 30, 2017 | -10.66% |
| Jun 30, 2017 | -6.27% |
| Mar 31, 2017 | -12.81% |
| Dec 31, 2016 | -14.59% |
| Sep 30, 2016 | -52.81% |
| Jun 30, 2016 | 3.42% |
| Mar 31, 2016 | 3.21% |
| Dec 31, 2015 | 3.58% |